About this Course
Innovations in health care – such as drugs, diagnostic tools and medical devices – can improve patients’ lives if they are safe, effective, economical and readily available. Health stakeholders use global health technology assessments (HTAs) to determine the clinical and cost effectiveness of health technologies and to ensure market access for patients. For the health care industry, market access involves developing strategies for medical product registration, technology assessments by local entities, pricing and reimbursement methods.
This course introduces students to the principles, methods and practices of global HTA and market access. We’ll present various approaches to organizing and conducting HTA, using examples from around the world. You’ll examine contemporary case studies and interviews with global HTA leaders to understand the processes used to evaluate evidence and make resource allocation decisions about health technologies. We’ll describe and discuss various market access instruments, including price negotiation, innovative access agreements and international price referencing.
WHAT YOU’LL LEARN
- The organization, processes and conduct of HTA bodies around the world
- How to synthesize and appraise evidence to support reimbursement and coverage decisions
- Ways to evaluate the role of thresholds, decision rules and novel financial access agreements by HTA agencies in the current environment
- How to understand and navigate the complexities of international price referencing arrangements
- Techniques for describing the emerging price negotiation environment in the United States